BEWICK CRESCENT SURGERY — All Prescriptions & Medications — Page 11
Practice Code: A83037 | NEWTON AYCLIFFE, DL5 5LH
Showing results 501-550 of 716
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 37 | 5,700 | £1.1K | +43.5% ▲ | |
| Tamsulosin and dutasteride hydrochloride | 36 | 1,080 | £398 | +3.0% ▲ |
| Glycerol | 35 | 864 | £137 | -0.2% vs avg |
| Modafinil | 35 | 4,710 | £420 | +67.9% ▲ |
| Terbinafine hydrochloride | 35 | 1,010 | £206 | -5.7% ▼ |
| Other toiletry preparations | 35 | 4,900 | £233 | -18.1% ▼ |
| Atomoxetine hydrochloride | 34 | 952 | £2.0K | +0.6% vs avg |
| Magnesium aspartate | 34 | 448 | £449 | +124.5% ▲ |
| Calcium acetate | 34 | 3,916 | £368 | +83.7% ▲ |
| Codeine phosphate | 33 | 16.4K | £813 | +129.9% ▲ |
| Acetic acid | 33 | 170 | £159 | +184.9% ▲ |
| Dimeticone (Barrier) | 33 | 9,050 | £170 | +124.3% ▲ |
| Zinc oxide | 32 | 752 | £106 | +54.7% ▲ |
| Dexamfetamine sulfate | 32 | 1,422 | £1.6K | -11.0% ▼ |
| Bupropion hydrochloride | 32 | 1,224 | £812 | +196.1% ▲ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 32 | 192.0K | £2.0K | -26.9% ▼ |
| Ivermectin | 32 | 1,605 | £930 | +50.5% ▲ |
| Chlorhexidine gluconate | 32 | 14.5K | £275 | +8.4% ▲ |
| 32 | 524 | £1.5K | +386.8% ▲ | |
| 32 | 645 | £75 | +19.1% ▲ | |
| Nadolol | 31 | 1,064 | £703 | +206.6% ▲ |
| Cabergoline | 31 | 432 | £785 | +99.9% ▲ |
| Pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier (0913142) | 31 | 22.6K | £879 | +289.3% ▲ |
| Indometacin | 31 | 2,254 | £138 | +97.0% ▲ |
| Phenazone/lidocaine | 31 | 465 | £263 | +203.1% ▲ |
| 31 | 490 | £906 | +12.0% ▲ | |
| 31 | 2,670 | £4.8K | -22.3% ▼ | |
| Heparinoid | 30 | 3,570 | £196 | +14.4% ▲ |
| 30 | 78 | £677 | +7.8% ▲ | |
| 30 | 31 | £447 | +249.3% ▲ | |
| Co-magaldrox (Magnesium/aluminium hydroxide) | 29 | 13.8K | £83 | +257.9% ▲ |
| Zinc oxide | 29 | 11.5K | £301 | +44.2% ▲ |
| 29 | 329 | £305 | +43.4% ▲ | |
| 29 | 1,200 | £457 | +42.3% ▲ | |
| Budesonide | 28 | 346 | £2.7K | +78.7% ▲ |
| Prednisolone sodium phosphate | 28 | 734 | £17.3K | +620.1% ▲ |
| Bempedoic acid/Ezetimibe | 28 | 770 | £1.4K | -54.1% ▼ |
| Glucagon | 28 | 34 | £391 | +84.1% ▲ |
| Denosumab | 28 | 37 | £6.8K | +2.9% ▲ |
| Degarelix | 28 | 28 | £3.3K | +61.3% ▲ |
| Light liquid paraffin | 28 | 17.6K | £323 | -17.7% ▼ |
| Clindamycin phosphate | 28 | 1,380 | £227 | +70.2% ▲ |
| 28 | 278 | £190 | +218.5% ▲ | |
| Quinine bisulfate | 27 | 756 | £137 | -30.5% ▼ |
| Betamethasone sodium phosphate | 27 | 1,623 | £221 | +119.6% ▲ |
| Diclofenac sodium | 27 | 1,350 | £976 | +12.7% ▲ |
| 27 | 780 | £2.2K | +27.7% ▲ | |
| 27 | 840 | £1.5K | +81.8% ▲ | |
| 27 | 460 | £852 | -17.8% ▼ | |
| Flupentixol hydrochloride | 26 | 1,890 | £121 | -20.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.